PRCT 8-K 2026-11-04

PROCEPT BioRobotics Corp (PRCT) 8-K dated 2026-11-04 — accession 0001588978-26-000036.

PROCEPT BioRobotics Corp (PRCT) is a medical devices company listed on US.

PROCEPT BioRobotics Corp filed a 8-K on 2026-11-04. Accession 0001588978-26-000036.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PRCT revenue for 2025-12-31 was $308.1M. Net income was -$95.6M. Revenue was up 37.2% from 2024-12-31 to 2025-12-31. PRCT currently screens at market cap $1.52B.

Not investment advice. The PRCT SEC hub lists recent forms. The stock page is the research view.